Gain Therapeutics Stock Forecast - Simple Regression
| GANX Stock | USD 2.97 0.21 6.60% |
The Simple Regression forecasted value of Gain Therapeutics on the next trading day is expected to be 3.76 with a mean absolute deviation of 0.38 and the sum of the absolute errors of 23.67. Gain Stock Forecast is based on your current time horizon.
The RSI of Gain Therapeutics' stock price is slightly above 63. This usually indicates that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Gain, making its price go up or down. Momentum 63
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.16) | EPS Estimate Current Year (0.65) | EPS Estimate Next Year (0.71) | Wall Street Target Price 7.6 | EPS Estimate Current Quarter (0.15) |
Using Gain Therapeutics hype-based prediction, you can estimate the value of Gain Therapeutics from the perspective of Gain Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Gain Therapeutics using Gain Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Gain using crowd psychology based on the activity and movement of Gain Therapeutics' stock price.
Gain Therapeutics Implied Volatility | 1.81 |
Gain Therapeutics' implied volatility exposes the market's sentiment of Gain Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gain Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gain Therapeutics stock will not fluctuate a lot when Gain Therapeutics' options are near their expiration.
The Simple Regression forecasted value of Gain Therapeutics on the next trading day is expected to be 3.76 with a mean absolute deviation of 0.38 and the sum of the absolute errors of 23.67. Gain Therapeutics after-hype prediction price | USD 2.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Gain Therapeutics to cross-verify your projections. Open Interest Against 2026-02-20 Gain Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Gain Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Gain Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Gain Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Gain Therapeutics' open interest, investors have to compare it to Gain Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Gain Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Gain. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Gain Therapeutics Additional Predictive Modules
Most predictive techniques to examine Gain price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Gain using various technical indicators. When you analyze Gain charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Gain Therapeutics Simple Regression Price Forecast For the 7th of January
Given 90 days horizon, the Simple Regression forecasted value of Gain Therapeutics on the next trading day is expected to be 3.76 with a mean absolute deviation of 0.38, mean absolute percentage error of 0.22, and the sum of the absolute errors of 23.67.Please note that although there have been many attempts to predict Gain Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Gain Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Gain Therapeutics Stock Forecast Pattern
| Backtest Gain Therapeutics | Gain Therapeutics Price Prediction | Buy or Sell Advice |
Gain Therapeutics Forecasted Value
In the context of forecasting Gain Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Gain Therapeutics' downside and upside margins for the forecasting period are 0.03 and 13.14, respectively. We have considered Gain Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Gain Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Gain Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.4508 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.3818 |
| MAPE | Mean absolute percentage error | 0.1387 |
| SAE | Sum of the absolute errors | 23.6732 |
Predictive Modules for Gain Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gain Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Gain Therapeutics
For every potential investor in Gain, whether a beginner or expert, Gain Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Gain Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Gain. Basic forecasting techniques help filter out the noise by identifying Gain Therapeutics' price trends.Gain Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gain Therapeutics stock to make a market-neutral strategy. Peer analysis of Gain Therapeutics could also be used in its relative valuation, which is a method of valuing Gain Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Gain Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Gain Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Gain Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Gain Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Gain Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gain Therapeutics shares will generate the highest return on investment. By undertsting and applying Gain Therapeutics stock market strength indicators, traders can identify Gain Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 163282.0 | |||
| Daily Balance Of Power | (0.48) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 3.05 | |||
| Day Typical Price | 3.02 | |||
| Price Action Indicator | (0.18) | |||
| Period Momentum Indicator | (0.21) | |||
| Relative Strength Index | 63.91 |
Gain Therapeutics Risk Indicators
The analysis of Gain Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Gain Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gain stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.07 | |||
| Semi Deviation | 8.89 | |||
| Standard Deviation | 9.28 | |||
| Variance | 86.08 | |||
| Downside Variance | 98.13 | |||
| Semi Variance | 79.1 | |||
| Expected Short fall | (6.55) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.